Candel Therapeutics, Inc.公布了2025财年第四季度及全年的财务业绩,同时分享了公司近期的战略动态。报告显示,公司在关键业务领域取得显著进展,并持续推动创新疗法的研发进程。财务数据反映了企业在优化运营效率与扩大临床管线方面的投入成果。
Candel Therapeutics, Inc.公布了2025财年第四季度及全年的财务业绩,同时分享了公司近期的战略动态。报告显示,公司在关键业务领域取得显著进展,并持续推动创新疗法的研发进程。财务数据反映了企业在优化运营效率与扩大临床管线方面的投入成果。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.